Vildagliptin preserved protective effects of ischemic preconditioning in diabetes, CAD

Links shared publicly online about this topic.

  • 1,061
    total visits

Vildagliptin preserved protective effects of ischemic preconditioning in diabetes, CAD

endocrinetoday.com

ADA 70th Scientific Sessions ORLANDO — Compared with repaglinide, vildagliptin did not affect the protective mechanism of myocardial isc

View full resource at endocrinetoday.com

Tags: Heart Disease, Circulatory Disorders, Atherosclerosis, Coronary Artery Disease, Diabetes, Thrombotic Event

  • Share

Most Recently Shared on June 28, 2010 at 3:27 pm By:

EndocrineToday Endocrine Today

Findings suggest vildagliptin preserved protective effects of ischemic preconditioning in #diabetes, CAD #ADA2010 http://ow.ly/24cXt

2 years ago...

Advertisement